excess mortality and morbidity rates. One of the more recent drug approvals that was later withdrawn was in 2004 for Merck's anti- inflammatory drug Rofecoxib (Vioxx •) which has been conservatively attributed with over 38,000 deaths in the US, and 60,000 worldwide. The number of deaths related to Vioxx •